Silgan Holdings (NYSE:SLGN) misses Q3 2026 revenue estimates

Silgan Holdings reported Q3 2026 revenue of $2.04 billion, missing estimates by 2.4%, but beat EPS estimates by 4.9%. The company raised its full-year adjusted EPS guidance to $3.88. Operating and free cash flow margins remained steady year-over-year.

Original reporting
Published Oct 29, 2026, 10:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Silgan Holdings (NYSE:SLGN) misses Q3 2026 revenue estimates — source image
Decision brief

The 30-second read

$SLGNNeutralMed
01

Why it matters

For traders, the key tension is a modest revenue miss versus a beat in adjusted EPS and a small guidance raise, which can shift expectations for margins and cash generation even if growth is softer.

02

Market read

Company-specific earnings print with guidance update, relevant for near-term positioning in industrial packaging names.

03

What to watch

Traders will likely focus on the implied drivers behind the revenue shortfall (volume vs pricing) and whether free cash flow margin stability indicates sustainable earnings quality.

Relevance 7/10Novelty 6/10Timing: pre-market/early trading following the Q3 results and guidance update

Background

The piece summarizes Silgan’s Q3 2026 results versus S&P analysts’ consensus and notes a full-year adjusted EPS guidance increase.

Company-level read

Ticker impact

$SLGNNeutralMedium confidence
Context

Silgan reported Q3 2026 revenue of $2.04B vs $2.09B consensus, while adjusted EPS was $1.31 vs $1.25 consensus and full-year EPS guidance was raised to $3.88.

Expected impact

Likely choppy trading, with downside pressure from the revenue miss offset by support from the raised full-year adjusted EPS guidance.

Evidence & confidence

The article provides a clear earnings-style datapoint (revenue miss) plus a countervailing catalyst (raised full-year EPS guidance). Without segment detail, the market reaction is likely to hinge on whether investors prioritize top-line growth or EPS/margin durability.

Market effects

Signals ongoing demand and pricing pressure risk for packaging/industrial end-markets, but also shows companies can offset with cost control.

No direct regional spillover beyond US small/mid-cap industrial sentiment.

Limited, as the disclosure is company-specific with no stated global macro shock.

Counterpoint

The guidance raise and EPS beat may dominate, implying the revenue miss is temporary and investors may re-rate the stock on earnings power rather than growth.

Key entities

  • Silgan Holdings

    Reported Q3 2026 revenue and adjusted EPS versus consensus, and raised full-year adjusted EPS guidance.

Related articles

$SLGNMedAI 8/10

What Silgan (SLGN) Said on Its Q3 Earnings Call

Silgan (SLGN) raised its full-year 2026 adjusted EPS outlook to $3.83-$3.93, up from $3.72 in 2025. Q4 adjusted EPS is projected at $0.76-$0.86. The company expects $450M in free cash flow for 2026. Silgan also discussed its planned acquisition of Trivium, expected to close in mid-2027, which will create two new packaging businesses.

$SLGNMed

Silgan Holdings Inc (SLGN) Q3 2026 Earnings Call Highlights: Record Adjusted EPS

Silgan Holdings (SLGN) reported Q3 2026 earnings with record adjusted EPS and raised guidance. Weak consumer demand impacted volumes, especially in food, beverage, and home care. Margins in dispensing and specialty closures declined for six quarters but are expected to stabilize in Q4. The Trivium acquisition will require investments and may pose execution risks. CEO Adam Greenlee highlighted growth in wet pet food, fragrance, and prescription pharma.

$SLGNHighAI 8/10

Silgan Q3 profit slips despite higher sales

Silgan reported a Q3 2026 net income decline to $105m ($0.99 per share) from $113.3m ($1.06 per share) year-over-year, despite a 2% sales increase to $2.04bn. EBIT fell to $191.7m. The company raised its 2026 adjusted earnings outlook to $3.83-$3.93 per share and announced a $3.4bn acquisition of Trivium Packaging.

$SLGNHighAI 8/10

Silgan Q3 Adjusted EPS Hits Record $1.31, Full-Year Guidance Midpoint Raised

Silgan Holdings (SLGN) reported Q3 2026 net sales of $2.04B and adjusted EPS of $1.31, up from $1.22 a year earlier. Full-year adjusted EPS guidance was raised to $3.83-$3.93. Net sales rose 2% YoY, while GAAP net income fell to $105M. The company expects 2026 free cash flow of $450M and capital expenditures of $310M. CEO Adam Greenlee highlighted the acquisition of Trivium as a transformative move.

$SLGNMedAI 8/10

SILGAN ANNOUNCES THIRD QUARTER 2026 RESULTS

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Silgan Holdings Inc. Exhibit 99.1 SILGAN ANNOUNCES THIRD QUARTER 2026 RESULTS; RAISES FULL YEAR EARNINGS ESTIMATE MIDPOINT H ighlights • Announced transformative portfolio acceleration through the acquisition of Trivium • Achieved double digit growth in dispensing products for ph